Thymocyte responsiveness to endogenous glucocorticoids is required for immunological fitness

Journal of Clinical Investigation

Volumn 122, Issue 7, 2012, Pages 2384-2394

  Mittelstadt, Paul R ^a   Monteiro, João P ^b   Ashwell, Jonathan D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; THYMOCYTE; VIRUS INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, VIRAL; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; GLUCOCORTICOIDS; GLYCOPROTEINS; ISOANTIGENS; LYMPH NODES; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; THYMOCYTES; THYMUS GLAND; VIRAL PROTEINS;

EID: 84862840315     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI63067     Document Type: Article

References (70)

1. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol. 2003;21:139-176. (Pubitemid 37174529)
2. von Boehmer H, et al. Thymic selection revisited: how essential is it? Immunol Rev. 2003;191:62-78.
3. Daniels MA, et al. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature. 2006;444(7120):724-729. (Pubitemid 44949596)
4. Johnson AL, et al. Themis is a member of a new metazoan gene family and is required for the completion of thymocyte positive selection. Nat Immunol. 2009;10(8):831-839.
5. Lesourne R, et al. Themis, a T cell-specific protein important for late thymocyte development. Nat Immunol. 2009;10(8):840-847.
6. Fu G, et al. Themis controls thymocyte selection through regulation of T cell antigen receptor-mediated signaling. Nat Immunol. 2009;10(8):848-856.
7. Vacchio MS, Lee JY, Ashwell JD. Thymus-derived glucocorticoids set the thresholds for thymocyte selection by inhibiting TCR-mediated thymocyte activation. J Immunol. 1999;163(3):1327-1333. (Pubitemid 29352751)
8. King LB, Vacchio MS, Dixon K, Hunziker R, Margulies DH, Ashwell JD. A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity. 1995;3(5):647-656.
9. Lu FW, et al. Thymocyte resistance to glucocorticoids leads to antigen-specific unresponsiveness due to "holes" in the T cell repertoire. Immunity. 2000; 12(2):183-192. (Pubitemid 30398632)
10. Tronche F, et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet. 1999;23(1):99-103. (Pubitemid 29418797)
11. Allen JM, Forbush KA, Perlmutter RM. Functional dissection of the lck proximal promoter. Mol Cell Biol. 1992;12(6):2758-2768.
12. Shimizu C, et al. Progression of T cell lineage restriction in the earliest subpopulation of murine adult thymus visualized by the expression of lck proximal promoter activity. Int Immunol. 2001;13(1):105-117. (Pubitemid 32060982)
13. Lee PP, et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity. 2001;15(5):763-774. (Pubitemid 34008504)
14. Schwartz JR, Sarvaiya PJ, Vedeckis WV. Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia. Mol Cell Endocrinol. 2010;320(1-2):76-86.
15. Galon J, et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 2002;16(1):61-71. (Pubitemid 34027951)
16. Franchimont D, et al. Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha. J Immunol. 2002;168(5):2212-2218. (Pubitemid 34171820)
17. Lowenberg M, et al. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood. 2005;106(5):1703-1710. (Pubitemid 41208584)
18. Bartis D, et al. Intermolecular relations between the glucocorticoid receptor, ZAP-70 kinase, and Hsp-90. Biochem Biophys Res Commun. 2007;354(1):253-258. (Pubitemid 46123227)
19. Garcia KC, Adams JJ, Feng D, Ely LK. The molecular basis of TCR germline bias for MHC is surprisingly simple. Nat Immunol. 2009;10(2):143-147.
20. Morris GP, Ni PP, Allen PM. Alloreactivity is limited by the endogenous peptide repertoire. Proc Natl Acad Sci U S A. 2011;108(9):3695-3700.
21. Matloubian M, Concepcion RJ, Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol. 1994;68(12):8056-8063. (Pubitemid 24362694)
22. Smith K, Seddon B, Purbhoo MA, Zamoyska R, Fisher AG, Merkenschlager M. Sensory adaptation in naive peripheral CD4 T cells. J Exp Med. 2001; 194(9):1253-1261. (Pubitemid 33055044)
23. Stefanova I, Dorfman JR, Germain RN. Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes. Nature. 2002;420(6914):429- 434. (Pubitemid 35415655)
24. Takada K, Jameson SC. Naive T cell homeostasis: from awareness of space to a sense of place. Nat Rev Immunol. 2009;9(12):823-832.
25. MacDonald HR, Budd RC, Howe RC. A CD3- subset of CD4-8+ thymocytes: a rapidly cycling intermediate in the generation of CD4+8+ cells. Eur J Immunol. 1988;18(4):519-523.
26. Mombaerts P, et al. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature. 1992; 360(6401):225-231.
27. Kaye J, Vasquez NJ, Hedrick SM. Involvement of the same region of the T cell antigen receptor in thymic selection and foreign peptide recognition. J Immunol. 1992;148(11):3342-3353.
28. Matechak EO, Killeen N, Hedrick SM, Fowlkes BJ. MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent. Immunity. 1996; 4(4):337-347. (Pubitemid 26174049)
29. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol. 2006;24:419-466.
30. Hedrick SM, et al. Selection of amino acid sequences in the beta chain of the T cell antigen receptor. Science. 1988;239(4847):1541-1544.
31. McHeyzer-Williams MG, Davis MM. Antigen-specific development of primary and memory T cells in vivo. Science. 1995;268(5207):106-111.
32. Robins HS, et al. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood. 2009;114(19):4099-4107.
33. Tolosa E, King LB, Ashwell JD. Thymocyte glucocorticoid resistance alters positive selection and inhibits autoimmunity and lymphoproliferative disease in MRL-lpr/lpr mice. Immunity. 1998;8(1):67-76. (Pubitemid 28097824)
34. Stephens GL, Ashwell JD, Ignatowicz L. Mutually antagonistic signals regulate selection of the T cell repertoire. Int Immunol. 2003;15(5):623-632. (Pubitemid 36519399)
35. van den Brandt J, et al. Enhanced glucocorticoid receptor signaling in T cells impacts thymocyte apoptosis and adaptive immune responses. Am J Pathol. 2007;170(3):1041-1053.
36. Purton JF, et al. Glucocorticoid receptor deficient thymic and peripheral T cells develop normally in adult mice. Eur J Immunol. 2002;32(12):3546-3555. (Pubitemid 36024391)
37. Cole TJ, et al. GRKO mice express an aberrant dexamethasone-binding glucocorticoid receptor, but are profoundly glucocorticoid resistant. Mol Cell Endocrinol. 2001;173(1-2):193-202. (Pubitemid 32149641)
38. Mittelstadt PR, Ashwell JD. Disruption of glucocorticoid receptor exon 2 yields a ligand-responsive C-terminal fragment that regulates gene expression. Mol Endocrinol. 2003;17(8):1534-1542. (Pubitemid 36930468)
39. Brewer JA, Kanagawa O, Sleckman BP, Muglia LJ. Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J Immunol. 2002;169(4):1837-1843. (Pubitemid 34857645)
40. Baumann S, et al. Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95-ligand gene by a glucocorticoid receptor dimer. Blood. 2005; 106(2):617-625. (Pubitemid 40981259)
41. Wiegers GJ, Kaufmann M, Tischner D, Villunger A. Shaping the T-cell repertoire: a matter of life and death. Immunol Cell Biol. 2011;89(1):33-39.
42. Oakley RH, Cidlowski JA. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem. 2011;286(5):3177-3184.
43. Krogsgaard M, Li QJ, Sumen C, Huppa JB, Huse M, Davis MM. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity. Nature. 2005;434(7030):238-243. (Pubitemid 40388057)
44. Kassiotis G, Garcia S, Simpson E, Stockinger B. Impairment of immunological memory in the absence of MHC despite survival of memory T cells. Nat Immunol. 2002;3(3):244-250. (Pubitemid 34213425)
45. Moran AE, Hogquist KA. T-cell receptor affinity in thymic development. Immunology. 2012; 135(4):261-267.
46. Vacchio MS, Papadopoulos V, Ashwell JD. Steroid production in the thymus: implications for thymocyte selection. J Exp Med. 1994;179(6):1835-1846. (Pubitemid 24155664)
47. Staton TL, et al. Dampening of death pathways by schnurri-2 is essential for T-cell development. Nature. 2011;472(7341):105-109.
48. Bouillet P, et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 2002;415(6874):922-926. (Pubitemid 34174755)
49. Cante-Barrett K, Gallo EM, Winslow MM, Crabtree GR. Thymocyte negative selection is mediated by protein kinase C- and Ca2+-dependent transcriptional induction of bim [corrected]. J Immunol. 2006;176(4):2299-2306. (Pubitemid 43201677)
50. Drakopoulou E, et al. Non-redundant role for the transcription factor Gli1 at multiple stages of thymocyte development. Cell Cycle. 2010;9(20):4144-4152.
51. Rincon M, et al. The JNK pathway regulates the In vivo deletion of immature CD4(+)CD8(+) thymocytes. J Exp Med. 1998;188(10):1817-1830. (Pubitemid 28536769)
52. McCarty N, Paust S, Ikizawa K, Dan I, Li X, Cantor H. Signaling by the kinase MINK is essential in the negative selection of autoreactive thymocytes. Nat Immunol. 2005;6(1):65-72. (Pubitemid 40136697)
53. Jimi E, Strickland I, Voll RE, Long M, Ghosh S. Differential role of the transcription factor NF-kappaB in selection and survival of CD4+ and CD8+ thymocytes. Immunity. 2008;29(4):523-537.
54. Palmer E, Naeher D. Affinity threshold for thymic selection through a T-cell receptor-co-receptor zipper. Nat Rev Immunol. 2009;9(3):207-213.
55. Kalergis AM, et al. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat Immunol. 2001; 2(3):229-234.
56. Calnan BJ, Szychowski S, Chan FK, Cado D, Winoto A. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity. 1995;3(3):273-282.
57. Martens C, Bilodeau S, Maira M, Gauthier Y, Drouin J. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor. Mol Endocrinol. 2005;19(4):885-897. (Pubitemid 40397054)
58. Moran AE, et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med. 2011; 208(6):1279-1289.
59. Kuang AA, Cado D, Winoto A. Nur77 transcription activity correlates with its apoptotic function in vivo. Eur J Immunol. 1999;29(11):3722-3728. (Pubitemid 29527821)
60. Thompson J, Winoto A. During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain. J Exp Med. 2008; 205(5):1029-1036. (Pubitemid 351679679)
61. Beaulieu E, Morand EF. Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis. Nat Rev Rheumatol. 2011;7(6):340-348.
62. Delfino DV, Agostini M, Spinicelli S, Vito P, Riccardi C. Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. Blood. 2004;104(13):4134-4141. (Pubitemid 39620166)
63. Delfino DV, Agostini M, Spinicelli S, Vacca C, Riccardi C. Inhibited cell death, NF-kappaB activity and increased IL-10 in TCR-triggered thymocytes of transgenic mice overexpressing the glucocorticoid-induced protein GILZ. Int Immunopharmacol. 2006; 6(7):1126-1134. (Pubitemid 43728169)
64. Wust S, et al. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J Immunol. 2008; 180(12):8434-8443.
65. Gascoigne NR, Palmer E. Signaling in thymic selection. Curr Opin Immunol. 2011;23(2):207-212.
66. Labrecque N, Baldwin T, Lesage S. Molecular and genetic parameters defining T-cell clonal selection. Immunol Cell Biol. 2011;89(1):16-26.
67. Kaye J, Hsu ML, Sauron ME, Jameson SC, Gascoigne NR, Hedrick SM. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature. 1989; 341(6244):746-749. (Pubitemid 19260889)
68. Hennet T, Hagen FK, Tabak LA, Marth JD. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. Proc Natl Acad Sci U S A. 1995;92(26):12070-12074.
69. Ohashi PS, et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 1991;65(2):305-317. (Pubitemid 121006060)
70. Dorfman JR, Stefanova I, Yasutomo K, Germain RN. CD4+ T cell survival is not directly linked to self-MHC-induced TCR signaling. Nat Immunol. 2000; 1(4):329-335.